0.63 USD
▼-0.04-6.33%
盘后 0.61 -2.76%
2026-11-20
市值
$11.53M
市盈率
—
EPS
-3.68
股息率
—
52 周区间
0.63 – 16.25
成交量
12.72K
Beta
0.87
目标价
16.44
52W 低 0.6352W 高 16.25
价格走势
公司简介
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs in the United States. The company develops RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. It is also...